Clinical Significance of SHBG 21 nmol/L
An SHBG level of 21 nmol/L is low and clinically significant, indicating increased bioavailability of sex hormones and suggesting underlying metabolic dysfunction, particularly insulin resistance, metabolic syndrome, or hyperandrogenism.
Interpretation Framework
The clinical significance depends critically on the patient's sex, age, and clinical context:
In Women
Low SHBG (21 nmol/L) strongly suggests hyperandrogenism and metabolic dysfunction. This level is typically seen in:
Polycystic Ovary Syndrome (PCOS): SHBG is normally reduced in the setting of overweight, metabolic syndrome, or family history of diabetes 1. Low SHBG increases free testosterone levels even when total testosterone appears normal, explaining hyperandrogenic symptoms like hirsutism and acne 1.
Insulin Resistance: The hyperinsulinemia of insulin resistance suppresses SHBG production 2. Low SHBG serves as a marker of insulin resistance and may predict increased risk for type 2 diabetes 3. SHBG levels are negatively correlated with both body mass index and fasting insulin levels 3.
Increased Cardiovascular Risk: Decreased SHBG levels are associated with increased overall mortality in postmenopausal women 3.
Clinical Action: When SHBG is low with clinical hyperandrogenism symptoms, calculate free or bioavailable testosterone rather than relying on total testosterone alone 1. The free testosterone level may be elevated when total testosterone is normal, making it more sensitive for detecting androgen excess 2. Screen for metabolic syndrome components, assess insulin resistance (HOMA-IR in non-diabetics), and evaluate for PCOS if irregular cycles or hirsutism are present.
In Men
SHBG of 21 nmol/L in adult men is at the lower end of normal or slightly low, suggesting:
Metabolic Syndrome/Insulin Resistance: Similar to women, low SHBG in men correlates with insulin resistance and is inversely associated with cardiovascular risk markers 3, 4.
Hypertension Risk: Lower SHBG levels are inversely associated with development of hypertension and increases in blood pressure 5.
Clinical Action: Assess for metabolic syndrome components, insulin resistance, and cardiovascular risk factors. In men with symptoms of hypogonadism, calculate free testosterone as low SHBG will increase bioavailable testosterone, potentially masking true hypogonadism.
Special Contexts
Important caveats to avoid misinterpretation:
Hypothyroidism: Hypothyroidism suppresses SHBG 2, 6. Check thyroid function (TSH, free T4) as treating hypothyroidism may normalize SHBG.
Medications: Androgens and drugs with androgenic effects lower SHBG. Review medication list.
Age Considerations: In prepubertal boys with hypopituitarism, SHBG levels are typically elevated (>120 nmol/L), so a level of 21 nmol/L would be inappropriately low and suggest isolated hypogonadotropic hypogonadism (Kallmann syndrome) rather than growth hormone deficiency 7.
Diagnostic Algorithm
Confirm the clinical context: Sex, age, symptoms (hirsutism, acne, menstrual irregularity, metabolic symptoms)
Calculate free or bioavailable testosterone: Use total testosterone and SHBG to compute free testosterone, as this is more accurate than direct free testosterone assays 2
Screen for metabolic dysfunction:
- Fasting glucose and insulin (calculate HOMA-IR if non-diabetic)
- Lipid panel
- Blood pressure
- BMI and waist circumference
Assess thyroid function: TSH and free T4 to exclude hypothyroidism as a cause 2, 6
In women with hyperandrogenic symptoms: Consider PCOS evaluation with additional testing (17-OHP if indicated, pelvic ultrasound) 1
The key clinical implication is that low SHBG increases bioavailable sex hormones and serves as a metabolic marker warranting comprehensive cardiometabolic risk assessment.